You are here

Policy

 

Mammography rates increased after the Affordable Care Act (ACA) eliminated cost sharing for preventive services recommended by the U.S. Preventive Services Task Force, according to a new study published by the New England Journal of Medicine.

One of healthcare’s most common debates is which of the many different breast cancer screening guidelines women should follow to receive the best possible care. The authors of a new study in the American Journal of Roentgenology ran a Monte Carlo computer simulation to put the screening mammography guidelines released by the American Cancer Society (ACS) in 2015 up against the updated recommendations released by the U.S. Preventive Services Task Force (USPSTF) in 2016.

Radiation oncologists should be more directly involved in the formal education of medical students, according to a new study published in the Journal of the American College of Radiology.

New research published in Current Problems in Diagnostic Radiology suggests procedural training should be standardized during residency and competence in specific procedures should be achieved at its completion.

The Merit-Based Incentive Payment System (MIPS), developed by CMS to pay physicians under the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, is one of many things today’s imaging leaders must understand to help their groups stay ahead. According to a recent study in the Journal of the American College of Radiology, CMS exempts certain physicians from participating in MIPS, but many radiologists will find they must participate.

 

Recent Headlines

NIH scientists to be limited on grant support

The U.S. National Institutes of Health (NIH) announced May 2 that a new policy will be put in place to restrict the amount of funding an individual scientist can hold at any one time by using a point-based system.

Samsung continues foray into diagnostic imaging with radiography unit

Samsung is adding a new digital radiography unit to its growing roster of medical imaging equipment, receiving FDA 501(k) approval for the GC70 Digital Radiography system.

RBMA PaRADigm 2017: Ben Wanamaker on some of healthcare's biggest issues—and how to fix them

Healthcare is in desperate need of a change, Ben Wanamaker explained during his keynote address Monday morning at RBMA PaRADigm 2017 in Chicago. Consumer costs are on the rise, pricing for basic services is widely inconsistent and the government is spending more and more tax dollars on policies such as social security, Medicare and Medicaid. 

Radiology should work with certified health records—not against them

Radiologists should understand the importance of using certified electronic health record (EHR) technology—now more than ever with the opening of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)’s first reporting period.

As Policies Evolve, Practice Leadership Must Remain Active

As research director of a policy think tank dedicated to medical imaging, I’m frequently asked how radiologists—and their practices—will fit into the broader healthcare landscape once the current tumultuous healthcare environment evolves into stable equilibrium. Of course, whether we do see a stable equilibrium is a questionable assumption in itself, but it doesn’t hurt to put on our futurist hats and explore how this may look for radiology. 

FDA approves first digital pathology system for diagnostic use

Royal Phillips has received U.S. Food and Drug Administration (FDA) clearance for its IntelliSite Pathology Solution, a pathology image creation and management system. Its currently the only digital pathology system cleared for primary diagnostic use, an important milestone in the burgeoning field.

USPSTF changes 2012 recommendation on PSA testing

Blood testing for prostate cancer now has a passing grade—the U.S. Preventative Services Task Force (USPSTF) has changed its tune on prostate-specific antigen (PSA) screening, upgrading the recommendation that some men undergo to a “C” grade.  

Legislation could modernize FDA regulations on imaging devices, contrast

Imaging advocacy groups have lined up to support a bill providing medical imaging device and contrast drug manufacturers a clear regulatory pathway, speeding the bench-to-bedside transition.

EU reconsiders pulling gadolinium contrast agents from market

The European Medicines Agency (EMA) will re-examine its decision to pull several gadolinium contrast agents from the European single market following requests from gadolinium producers.

Imaging growth leveling off due to reimbursement cuts, changes in ordering

The dramatic growth in imaging utilization experienced at the beginning of the millennium has mostly leveled off, according to a study published in Health Affairs, primarily due to major cuts to reimbursement and more careful ordering of noninvasive exams.

Pages